|
|
|
Plant - Mandideep, Madhya Pradesh state, India |
|
-
Manufactures both APIs and finished dosages
-
World's largest producer of lisinopril API
-
Forms the hub of Lupin's competencies in cephalosporins
and prils
-
Manufactures both oral and injectable cephalosporins
-
Main products: cephalosporins, lisinopril, other prils
|
|
Major products
|
|
Product
|
Therapeutic area
|
API
|
Finished dosage
|
|
|
|
Oral
|
Injectable
|
|
|
|
|
Cefotaxime sodium |
Anti-bacterial |
|
|
|
|
|
Cephalexin |
Anti-bacterial |
|
|
|
|
|
Cefadroxil |
Anti-bacterial |
|
|
|
|
|
Ceftazidime |
Anti-bacterial |
|
|
|
|
|
Cefuroxime
axetil (A) |
Anti-bacterial |
|
|
|
|
|
Cefuroxime
axetil (C) |
Anti-bacterial |
|
|
|
|
|
|
|
|
|
Lisinopril |
Cardiovascular |
|
|
|
|
|
E-DMF
in more than
20 European countries
including UK |
|
|
|
|
Benazepril |
Cardiovascular |
|
|
|
|
| |
|
|
|
US
Food and Drug Administration |
|
|
UK
Medicine Control Authority |
|
Abbreviated Antibiotic Drug Application
(Now considered as DMF in US) |
|
European Drug Master File |
 |
Certificate of Suitability submitted to European Directorate
of Quality of Medicine |
|
|
 |
|
|
